Manonai J,Theppisai U,Suthutvoravut S.The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women:a comparative study.Obstetrics and Gynecology. 2001Manonai J,Theppisai U,Suthutvoravut S.The effect of estradiol vaginal tablet and ...
This study compared the effectiveness and user-friendliness of Vagifem (an estradiol vaginal tablet) and vaginal estrogen cream in the treatment of atrophic vaginitis. One hundred and sixty postmenopausal women with symptoms of atrophic vaginitis were randomly divided into two groups of treatment with ...
Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, consider addition of a progestogen to reduce the risk of endometrial cancer. Generally, a woman without a uterus does not need to use a progestogen in addition to her estrogen therapy. In some cases, however, hyst...
Mean was 0.31 for vaginal tablet users; 0.27 for vaginal cream users (p = 0.117). Treatment duration over two years of follow-up was similar for both forms of vaginal (296 days for vaginal tablets vs. 280 days for vaginal cream, p = 0.607). Tablet users refilled their first prescription...
Estragyn (estrone) 0.1% W/W Vaginal Cream is a form of the female hormoneestrogenused for short-term treatment of menopausal andpostmenopausalsymptoms. What Are Side Effects of Estragyn? Common side effects of Estragyn Vaginal Cream include: ...
Estrogen therapy may exacerbateasthma,diabetes mellitus,epilepsy, migraine,porphyria,systemic lupus erythematosus, and hepatic hemangiomas; consider whether the benefits of estrogen therapy outweigh the risks in women with these conditions Localabrasioninduced by vaginal tablet applicator reported ...
普力馬林陰道乳膏PremarinVaginalCream衛署藥輸字第019489號本藥須由醫師處方使用警語使用普力馬林陰道乳膏可能會有全身性的藥效,因此亦應留意普力馬林口服製劑說明書中..
premarin阴道雌激素普力马林vaginalcream 普马阴道乳膏PremarinVaginalCream卫署药输字第019489号本药须由医师处方使用警语使用普马阴道乳膏可能会有全身性的药效,因此亦应意普马口服制剂明书中警语、注意事项及反应等章节所提及的情形。雌激素会增加子宫内膜癌的发生妇使用雌激素制剂时,应密注意其床表现,病人出现任何原因...
Tablet users refilled their first prescription at a significantly higher rate (48.8% for vaginal tablets, 35.3% for vaginal cream, p = 0.001) but more often switched to the other form of vaginal estrogen (4.4% vs. 1.7%, p = 0.023). Annual obstetrician/gynecologist and primary care physician...